These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 11119429)

  • 1. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
    Ceballos-Salobreña A; Gaitán-Cepeda LA; Ceballos-Garcia L; Lezama-Del Valle D
    AIDS Patient Care STDS; 2000 Dec; 14(12):627-35. PubMed ID: 11119429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short communication: oral lesions in HIV/AIDS patients undergoing HAART including efavirenz.
    Aquino-García SI; Rivas MA; Ceballos-Salobreña A; Acosta-Gio AE; Gaitán-Cepeda LA
    AIDS Res Hum Retroviruses; 2008 Jun; 24(6):815-20. PubMed ID: 18507528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing prevalence of human immunodeficiency virus-associated oral lesions.
    Dios PD; Ocampo A; Miralles C; Limeres J; Tomás I
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):403-4. PubMed ID: 11027372
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.
    Nicolatou-Galitis O; Velegraki A; Paikos S; Economopoulou P; Stefaniotis T; Papanikolaou IS; Kordossis T
    Oral Dis; 2004 May; 10(3):145-50. PubMed ID: 15089923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
    Lebbé C; Blum L; Pellet C; Blanchard G; Vérola O; Morel P; Danne O; Calvo F
    AIDS; 1998 May; 12(7):F45-9. PubMed ID: 9619797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.
    Gulick RM; Mellors JW; Havlir D; Eron JJ; Gonzalez C; McMahon D; Richman DD; Valentine FT; Jonas L; Meibohm A; Emini EA; Chodakewitz JA
    N Engl J Med; 1997 Sep; 337(11):734-9. PubMed ID: 9287228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of highly active antiretroviral therapy on frequency of oral warts.
    Greenspan D; Canchola AJ; MacPhail LA; Cheikh B; Greenspan JS
    Lancet; 2001 May; 357(9266):1411-2. PubMed ID: 11356441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral lesions in Brazilian HIV-infected children undergoing HAART.
    Miziara ID; Filho BC; Weber R
    Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1089-96. PubMed ID: 16406081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS).
    Greenspan D; Komaroff E; Redford M; Phelan JA; Navazesh M; Alves ME; Kamrath H; Mulligan R; Barr CE; Greenspan JS
    J Acquir Immune Defic Syndr; 2000 Sep; 25(1):44-50. PubMed ID: 11064503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral candidosis as a clinical marker of immune failure in patients with HIV/AIDS on HAART.
    Gaitán-Cepeda LA; Martínez-González M; Ceballos-Salobreña A
    AIDS Patient Care STDS; 2005 Feb; 19(2):70-7. PubMed ID: 15716638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden.
    Patton LL
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Aug; 90(2):182-8. PubMed ID: 10936837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients.
    Hengge UR; Goos M; Esser S; Exner V; Dötterer H; Wiehler H; Borchard C; Müller K; Beckmann A; Eppner MT; Berger A; Fiedler M
    AIDS; 1998 Dec; 12(17):F225-34. PubMed ID: 9863864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing morbidity of cutaneous diseases in patients with HIV after the introduction of highly active antiretroviral therapy including a protease inhibitor.
    Calista D; Morri M; Stagno A; Boschini A
    Am J Clin Dermatol; 2002; 3(1):59-62. PubMed ID: 11817969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of HIV-related oral manifestations and their association with HAART and CD4+ T cell count: a review.
    Ottria L; Lauritano D; Oberti L; Candotto V; Cura F; Tagliabue A; Tettamanti L
    J Biol Regul Homeost Agents; 2018; 32(2 Suppl. 1):51-59. PubMed ID: 29460518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.
    Bravo IM; Correnti M; Escalona L; Perrone M; Brito A; Tovar V; Rivera H
    Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E33-9. PubMed ID: 16388291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of HIV associated oral lesions among adults in the era of HAART.
    Mthethwa SR; Wanjau J; Chabikuli N
    SADJ; 2013 Sep; 68(8):364-71. PubMed ID: 24660404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
    Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
    J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral manifestations of HIV infection in adult patients from the province of Sancti Spiritus, Cuba.
    Carpio E; López V; Fardales V; Benítez I
    J Oral Pathol Med; 2009 Jan; 38(1):126-31. PubMed ID: 19192058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.